A detailed history of Eqis Capital Management, Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Eqis Capital Management, Inc. holds 6,410 shares of BSX stock, worth $583,758. This represents 0.04% of its overall portfolio holdings.

Number of Shares
6,410
Previous 6,428 0.28%
Holding current value
$583,758
Previous $495,000 8.48%
% of portfolio
0.04%
Previous 0.04%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$72.96 - $84.0 $1,313 - $1,512
-18 Reduced 0.28%
6,410 $537,000
Q2 2024

Aug 13, 2024

BUY
$67.33 - $77.71 $161,861 - $186,814
2,404 Added 59.74%
6,428 $495,000
Q1 2024

May 14, 2024

BUY
$57.6 - $68.62 $231,782 - $276,126
4,024 New
4,024 $275,000
Q2 2023

Aug 14, 2023

BUY
$49.72 - $54.64 $199,128 - $218,833
4,005 New
4,005 $216,000
Q3 2019

Nov 05, 2019

SELL
$40.31 - $43.45 $317,360 - $342,081
-7,873 Closed
0 $0
Q2 2019

Jul 18, 2019

BUY
$34.91 - $42.98 $274,846 - $338,381
7,873 New
7,873 $338,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $130B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Eqis Capital Management, Inc. Portfolio

Follow Eqis Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Eqis Capital Management, Inc. with notifications on news.